120 related articles for article (PubMed ID: 4212805)
1. [Selective action of neuroleptics on the cholinergic neurons of the neostriatum in the rat: antagonism to apomorphine].
Guyenet P; Agid Y; Javoy F; Beaujouan JC; Glowinski J
C R Acad Hebd Seances Acad Sci D; 1974 May; 278(21):2679-82. PubMed ID: 4212805
[No Abstract] [Full Text] [Related]
2. Effects of dopaminergic receptor agonists and antagonists on the activity of the neo-striatal cholinergic system.
Guyenet PG; Javory AF; Beaujouan JC; Rossier BJ; Glowinski J
Brain Res; 1975 Feb; 84(2):227-44. PubMed ID: 234276
[TBL] [Abstract][Full Text] [Related]
3. Interaction of apomorphine, neuroleptics and stimulants with alpha-methyl-m-tyramine, a false dopaminergic transmitter.
Dorris RL; Shore PA
Biochem Pharmacol; 1974 Feb; 23(4):867-72. PubMed ID: 4150986
[No Abstract] [Full Text] [Related]
4. Changes of kinetic constant of striatal tyrosine hydroxylase elicited by neuroleptics that impair the function of dopamine receptors.
Zivkovic B; Guidotti A
Brain Res; 1974 Oct; 79(3):505-9. PubMed ID: 4153770
[No Abstract] [Full Text] [Related]
5. Dopamine receptors and cholinergic neurons in the rat neostriatum.
Guyenet PG; Javoy F; Agid Y; Beaujouan JC; Glowinski J
Adv Neurol; 1975; 9():43-51. PubMed ID: 238376
[No Abstract] [Full Text] [Related]
6. Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction.
Randrup A
Mod Probl Pharmacopsychiatry; 1970; 5():60-5. PubMed ID: 5527170
[No Abstract] [Full Text] [Related]
7. Tolerance to increases in striatal acetylcholine concentrations after repeated administration of apomorphine dipivaloyl ester.
Scatton B; Worms P
J Pharm Pharmacol; 1979 Dec; 31(12):861-3. PubMed ID: 43377
[No Abstract] [Full Text] [Related]
8. Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol.
Asper H; Baggiolini M; Burki HR; Lauener H; Ruch W; Stille G
Eur J Pharmacol; 1973 Jun; 22(3):287-94. PubMed ID: 4738903
[No Abstract] [Full Text] [Related]
9. Apomorphine stereotypies and transmitter mechanisms in the striatum. II. Interactions between GABA-ergic and cholinergic transmission.
Georgiev VP; Petkova BP
Acta Physiol Pharmacol Bulg; 1978; 4(3):65-70. PubMed ID: 220844
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanisms in the rat striatum.
Iversen LL; Rogawski MA; Miller RJ
Mol Pharmacol; 1976 Mar; 12(2):251-62. PubMed ID: 4724
[No Abstract] [Full Text] [Related]
11. Neurophysiological substrates of the pharmacological criteria for neuroleptics.
Stille G
Mod Probl Pharmacopsychiatry; 1970; 5():56-60. PubMed ID: 5527169
[No Abstract] [Full Text] [Related]
12. Does a true qualitative difference exist in the mode of action of neuroleptics and thymanaleptics on catecholamine neuron systems.
Moller Nielsen I
Mod Probl Pharmacopsychiatry; 1970; 5():68-70. PubMed ID: 5527172
[No Abstract] [Full Text] [Related]
13. Reactions to apomorphine and spiroperidol of rats with striatal lesions: the relevance of kind and size of the lesion.
Wolfarth S
Pharmacol Biochem Behav; 1974; 2(2):181-6. PubMed ID: 4597891
[No Abstract] [Full Text] [Related]
14. Differential subsensitivity of dopaminergic and neostriatal neurons to apomorphine with long-term treatment.
Rebec GV; Lee EH
Brain Res; 1982 Oct; 250(1):188-92. PubMed ID: 7139316
[TBL] [Abstract][Full Text] [Related]
15. Limiting factors in the antagonism of neuroleptics on dopamine-sensitive adenylate cyclase.
Laduron P
J Pharm Pharmacol; 1976 Mar; 28(3):250-1. PubMed ID: 6703
[No Abstract] [Full Text] [Related]
16. Blockade of apomorphine's discriminative stimulus properties: relation to neuroleptic activity in neuropharmacological and biochemical assays.
Colpaert FC; Leysen JE; Niemegeers CJ; Janssen PA
Pharmacol Biochem Behav; 1976 Dec; 5(6):671-9. PubMed ID: 1035804
[TBL] [Abstract][Full Text] [Related]
17. Interaction between cholinergic and catecholaminergic neurones in rat brain.
Corrodi H; Fuxe K; Lidbrink P
Brain Res; 1972 Aug; 43(2):397-416. PubMed ID: 4403347
[No Abstract] [Full Text] [Related]
18. Apomorphine stereotypies and transmitter mechanisms in the striatum. I. Changes in the apomorphine stereotypies caused by drugs acting on the GABA-ergic, dopaminergic and cholinergic transmission.
Georgiev VP; Markovska VL; Petkova BP
Acta Physiol Pharmacol Bulg; 1978; 4(3):56-64. PubMed ID: 220843
[TBL] [Abstract][Full Text] [Related]
19. Cholinergic lesions of mouse striatum induced by AF64A alter D2 dopaminergic behavior and reduce D2 dopamine receptors and D2 dopamine receptor mRNA.
Zhou LW; Zhang SP; Connell TA; Weiss B
Neurochem Int; 1993 Mar; 22(3):301-11. PubMed ID: 8443571
[TBL] [Abstract][Full Text] [Related]
20. The effect of butaclamol and of other neuroleptic agents on the apomorphine-elicited inhibition of synaptosomal tyrosine hydroxylase activity.
Bronaugh RL; Tabak J; Ohashi T; Goldstein M
Psychopharmacol Commun; 1975; 1(5):501-10. PubMed ID: 7003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
